Dr. Brastianos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
# Massachu
Boston, MA 02114Phone+1 617-724-4000
Summary
- Dr. Priscilla Brastianos is an oncologist in Boston, MA and is affiliated with Massachusetts General Hospital (MGH). She is Director of the CNS Metastasis Center at MGH. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice 11 years.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2009 - 2012
- Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
- Johns Hopkins University School of MedicineClass of 2006
- University of British ColumbiaB.S., Biochemistry and Chemistry, 1998 - 2002
Certifications & Licensure
- NH State Medical License 2022 - 2026
- RI State Medical License 2022 - 2026
- FL State Medical License 2022 - 2025
- MA State Medical License 2009 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Jayne Koskinas Memorial Lecture Jayne Koskinas Ted Giovanis Foundation for Health and Policy and Leadership, 2019
- Harvard Medical School Teaching Award 2018
- University of Alberta CRINA lectureship Canadian Neuro-Oncology Meeting, 2018
- Join now to see all
Clinical Trials
- Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas Start of enrollment: 2015 Aug 01
- Pembrolizumab In Central Nervous System Metastases Start of enrollment: 2016 Oct 01
- Palbociclib In Progressive Brain Metastases Start of enrollment: 2017 Feb 14
- Join now to see all
Publications & Presentations
PubMed
- 199 citationsPervasive chromosomal instability and karyotype order in tumour evolution.Thomas B.K. Watkins, Emilia L. Lim, Marina Petkovic, Sergi Elizalde, Nicolai Juul Birkbak
Nature. 2020-09-02 - 1235 citationsAn Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCyril Neftel, Julie Laffy, Mariella G. Filbin, Toshiro Hara, Marni E. Shore
Cell. 2019-08-08 - 207 citationsInhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysisNathan Mathewson, Orr Ashenberg, Itay Tirosh, Simon Gritsch, Elizabeth M. Perez
Cell. 2021-03-04
Journal Articles
- Toward Precision Medicine in Brain MetastasesPriscilla Brastianos, MD, Thieme
- The Dual PI3K/mTOR-pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain MetastasesPriscilla K Brastianos, Daniel P Cahill, Clinical Cancer Research
- DMD Genomic Deletions Characterize a Subset of progressive/higher-grade Meningiomas with Poor OutcomeGanesh M Shankar, Sandro Santagata, Priscilla K Brastianos, Daniel P Cahill, Acta Neuropathologica
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Genetic characterization demonstrates high frequency of clinically actionable mutations in SMO and AKT1 in skull base meningiomasBrastianos, P.K., Society for Neuro-Oncology International Meningioma Meeting, Toronto, ON, Canada, 1/1/2016
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Metastasis-specific MutationsBrastianos, P.K., Clonal Evolution Symposium, AACR National Meeting, Philadelphia, PA, 1/1/2015
- Modes of metastasis in human and murine cancer revealed by whole exome sequencingCarter, S.L., Brastianos, P.K., Mcfadden, D.G., Papagiannokopoulos, T., Taylor-Weiner, A., Cibulskis, K., Jacks, T., Hahn, W.C., Getz, G, American Association for Cancer Research, San Diego, CA, 1/1/2014
- Join now to see all
Lectures
- Will There Ever Be Progress for Leptomeningeal Carcinomatosis: An Update on the Multidisciplinary...ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019
- How Can We Apply Precision Medicine to Craniopharyngioma and Meningioma?2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Phase II study of pembrolizumab in leptomeningeal carcinomatosis.2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
- Join now to see all
Authored Content
- Brain Metastasis from Squamous Cell Carcinoma of the Head and Neck: A Review of the Literature in the Genomic Era RelatedJune 2018
Press Mentions
- World Cancer Research Day: How MGH Research Scholars Are Helping to Move the Field ForwardSeptember 24th, 2024
- Kazia Launches New Scientific Advisory Board Comprised of World-Leading Experts in Brain CancerJuly 12th, 2022
- Phase Ii Study of Paxalisib in Brain Metastases Advances to Expansion Stage in Breast Cancer Brain Metastases CohortJune 7th, 2022
- Join now to see all
Professional Memberships
- Member
External Links
- Brastianos labhttp://brastianoslab.mgh.harvard.edu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: